Dismuzyme Plus 5000
Biotics Research Dismuzyme Plus 5000 is an 'Other Combinations' supplement featuring six ingredients, including Superoxide Dismutase and Peroxidases. It also contains 50 mcg of Selenium, which is at a clinically studied dose, alongside 0.5 mg Zinc, 0.1 mg Copper, and 0.5 mg Manganese. The product received an N+ Score of 37, earning an 'F' grade, indicating a poor overall quality assessment. While Selenium is adequately dosed, Zinc, Copper, and Manganese are identified as underdosed, which may limit their potential benefits. The supplement offers 100% label transparency, but its low N+ Score reflects significant concerns regarding ingredient adequacy and formula completeness. This product could be considered by those interested in superoxide dismutase with a clinically dosed selenium, despite other minerals being underdosed.
About This Product
Dismuzyme Plus 5000 by Biotics Research is a vitamins & minerals supplement containing 6 active ingredients. It has earned an N+ Score of 37/100 (Grade F).
Notable clinical-dose ingredients include Selenium.
N+ Score Breakdown
Are key ingredients present at clinically effective doses based on research?
Does the product include all expected ingredients for its supplement category?
Are individual ingredient amounts clearly disclosed without proprietary blends?
Does the formula include a breadth of beneficial compounds from multiple pathways?
Strengths
- +Fully transparent label with individual ingredient amounts disclosed
- +1 ingredient(s) at clinical dose levels
Weaknesses
- −Several ingredients below clinically effective doses
- −Missing several expected ingredients for its category
Ingredient Analysis (6 ingredients)
| Ingredient | Amount | Dose Adequacy |
|---|---|---|
| Zinc | 0.500 mg | Under |
| Selenium | 50.000 mcg | Adequate |
| Copper | 0.100 mg | Under |
| Manganese | 0.500 mg | Under |
| Superoxide Dismutase | 5000.000 Unit(s) | N/A |
| Peroxidases | 5000.000 Unit(s) | N/A |
Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.